Discover 379 paid clinical trials in Norfolk, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 379
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Norfolk VA, Morehead City NC, Washington D.C. DC,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07231419
Phase 3, Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for
Cardiovascular Disease
Location: Norfolk VA, Suffolk VA, Newport News VA, Midlothian VA,
Sponsor: Amgen
Sex: All
Age: 50 - 70+
Code: NCT07136012
Phase 3, Recruiting
Active & Responsive
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
for
Obesity, Overweight
Location: Norfolk VA, Hyattsville MD, Baltimore MD, Monroe NC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07321886
Phase 3, Recruiting
Active & Responsive
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
for
Healthy
Location: Norfolk VA, North Chesterfield VA, Richmond VA,
Sponsor: Pfizer
Sex: All
Age: 0 - 49
Code: NCT07160244
Phase 3, Recruiting
Active & Responsive
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
for
Lichen Planopilaris
Location: Norfolk VA, Richmond VA, Durham NC, Roanoke VA,
Sponsor: Priovant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07532603
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Virginia Beach VA, Burke VA, Philadelphia PA,
Sponsor: Expedition Therapeutics, Inc
Sex: All
Age: 40 - 70+
Code: NCT07684820
Phase 2, Recruiting
Active & Responsive
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
for
Primary Sjogren's Disease
Location: Chesapeake VA, Durham NC, Rockville MD, Philadelphia PA,
Sponsor: Vor Biopharma
Sex: All
Age: 18 - 70+
Code: NCT07404865
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
for
Rheumatoid Arthritis
Location: Chesapeake VA, Duncansville PA, The Bronx NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07137598
Phase 2, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Norfolk VA, Clinton MD, Washington D.C. DC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase 3, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Norfolk VA, Washington D.C. DC, Fairfax VA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase 3, Recruiting
Active & Responsive
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
for
Breast Neoplasms, Brain Neoplasms, Neoplasms by Site, Neoplasms,
Location: Norfolk VA, Centerville OH, Boston MA, Detroit MI,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05386108
Phase 1, Phase 2, Recruiting
Active & Responsive
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
for
Breast Neoplasms, Breast Cancer
Location: Norfolk VA, Nashville TN, Skokie IL, Dallas TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06797635
Phase 2, Recruiting
Active & Responsive
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for
Carcinoma, Non-Small-Cell Lung
Location: Norfolk VA, Richmond VA, Fairfax VA, Rockville MD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06623422
Phase 3, Recruiting
Active & Responsive
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
for
Immune Thrombocytopenic Purpura (ITP)
Location: Norfolk VA, Greenville NC, Washington D.C. DC,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06722235
Phase 3, Recruiting
Active & Responsive
Comparing Structured Retrieval Practice and Reading-Based Education for Dementia Caregivers
for
Dementia, Alzheimer Disease, Caregiver Stress
Location: Virginia Beach VA
Sponsor: Virginia Wesleyan University
Sex: All
Age: 50+
Code: NCT07413406
Recruiting
Active & Responsive
Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults
for
COVID-19
Location: Portsmouth VA, Columbus GA, Winter Park FL,
Sponsor: Ocugen
Sex: All
Age: 18+
Code: NCT05258669
Phase 2, Phase 3, Recruiting
Active & Responsive
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
for
Urinary Incontinence,Stress
Location: Virginia Beach VA, Newport News VA, Erie PA,
Sponsor: Eli Lilly and Company
Sex: Female
Age: 18+
Code: NCT07202884
Phase 3, Recruiting
Active & Responsive
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
for
Opioid Use Disorder
Location: Hampton VA, Wilmington DE, Salem VA, Philadelphia PA,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT04375033
Recruiting
Active & Responsive
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
for
Breast Cancer, Breast Neoplasm, Breast Tumor,
Location: Hampton VA, Fairfax VA, Baltimore MD, New York NY,
Sponsor: Proton Collaborative Group
Sex: Female
Age: 50+
Code: NCT01766297
Phase 2, Recruiting
Active & Responsive
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
for
Breast Cancer Female
Location: Newport News VA, Richmond VA, Culpeper VA,